SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-007464
Filing Date
2024-02-21
Accepted
2024-02-21 20:01:38
Documents
1
Period of Report
2024-02-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3736
  Complete submission text file 0001493152-24-007464.txt   5274
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address
Lbiati Kaouthar (Reporting) CIK: 0001938708 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36856 | Film No.: 24661879